Fasoracetam Capsules

Fasoracetam is a nootropic compound in the racetams group.

• Fasoracetam (N-(5-Oxo-D-prolyl)piperidine) (ref)* and its mechanism of action is not fully understood at this time.

The pre-clinical animal studies, indicate that Fasoracetam modulates and activates the metabotropic glutamate receptors (mGluR) (2)*.  Pre-clinical animal studies demonstrate Fasoracetam’s ability to increase acetylcholine release, uptake, and GABAb (3).*

• Assured Purity: Rigorously tested for quality & purity by third-party Certificate of Analysis*

Fasoracetam Chemical Properties

• Molecular formula: C₁₀H₁₆N₂O₂
• Molar mass: 25 g/mol
• CAS number: 110958-19-5 (1)
• Also known as: NS-105 (1)

Fasoracetam Capsules

Pure Nootropics’ offers Fasoracetam in 20 mg capsules.

Fasoracetam Reviews

See our Review Tab for more.

For further information, please see our References Tab above.

Notice: This product is a chemical compound. All chemicals have risks. This product is not approved by the FDA. Please research and understand the associated risks before handling. None of the information provided in our references are meant to be considered comprehensive or representative of the entire body of research on this compound. Please consult a qualified professional if you are unsure of how to handle this chemical. Misuse of this product may result in adverse reactions.

FASORACETAM CERTIFICATE OF ANALYSIS 02/2018

The references below are not meant to imply that any of our products treat, cure, or diagnose any disease or human condition. This product is sold as a research chemical and is for research purposes only; we recommend consulting a professional about how to handle this chemical. References to clinical studies and pre-clinical studies may use varying dosages and may not represent the dosages or subsequent results of products we sell; however, the references provided are pertinent to the subject supplement itself. References provided are intended for research and informational purposes only and do not represent the entire body of knowledge available on the subject(s) referenced; nor do they represent all possible outcomes associated with the subject(s) referenced including, but not limited to, adverse effects, precautions, or chemical interactions within the human body. The Content provided on this website is not intended to be a replacement for professional medical advice, treatment or diagnosis. Never ignore the advice of a medical professional or delay in attaining professional advice because of information or impressions you gather on this website. Choosing to rely on any information provided by the Content of this website is solely at your own risk. We encourage our audience to do their own research beyond the resources we have provided so your decision is as educated as possible.

1. “Fasoracetam.” PubChem Open Chemistry Database, pubchem.ncbi.nlm.nih.gov/compound/198695#section=Top.
2. Moskowitz, D. H., Dr. Finding the Genetic Cause…A Journey into the Precision Medicine that Could Affect Millions Worldwide. 30 Jan 2017, BookBaby. ISBN: 1483590984, 9781483590981.
3. Elia, Josephine et al. “Fasoracetam….and…glutamatergic gene network variants disrupting mGluR neurotransmitter signaling” Nature communications vol. 9,1 4. 16 Jan. 2018, doi:10.1038/s41467-017-02244-2.
4. Kumagai Y, Yokota S, Isawa S, Murasaki M, Mukai H, Miyatake S. Comparison of pharmacokinetics of NS-105…in elderly and young subjects. Int J Clin Pharmacol Res. 1999;19(1) 1-8. PMID: 10450537. http://europepmc.org/abstract/med/10450537.
5. Mukai, Hideya et al. Pharmacokinetics of NS-105, a Novel Cognition Enhancer, Arzneimittelforschung. 1999. 49 (11), pp. 881-890. DO – 10.1055/s-0031-1300521. https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1300521.
6. Findling, Robert, and Helen R. Stulman. “Transforming…Paradigms….” Aevi Genomic Medicine, 29AD, aevigenomicmedicine.gcs-web.com/static-files/550762a8-6d9f-4cd6-933f-5ff7e8e12ab8.